UEU-co logo

AccessMedicine

    Print   Close Window
Note: Large images and tables on this page may necessitate printing in landscape mode.

Copyright © The McGraw-Hill Companies.  All rights reserved.

CURRENT Diagnosis & Treatment in Cardiology > Chapter 35. Thoracic Aortic Aneurysms & Dissections >

Aneurysms

Essentials of Diagnosis

  • Ascending aortic diameter > 4 cm on imaging study.
  • Descending aortic diameter > 3.5 cm on imaging study.

General Considerations

In the ascending aorta, aneurysms tend to take on three common patterns, as indicated in Figure 35–1. These include the supracoronary aortic aneurysm, annuloaortic ectasia (marfanoid), and tubular diffuse enlargement.

Figure 35–1.

The three common patterns of ascending aortic aneurysm.

The most common pattern is that of supracoronary dilatation of the ascending aorta. In this pattern of disease, the short segment of aorta between the aortic annulus and the coronary arteries remains normal in size. Sinuses are “preserved,” meaning that the aorta indents normally, forming a “waist,” near the level of the coronary arteries. For this type of aneurysm, a supracoronary tube graft suffices.

In the second type, annuloaortic ectasia, the aortic annulus itself becomes dilated, giving a shape to the aorta like an Erlenmeyer chemistry flask. In this type of disease, the segment of aorta between the annulus and the coronary arteries is diseased, dilated, and thinned. Sinuses are “effaced,” meaning that the normal indentation, or waist, is lost. When surgery is required, the entire aortic root must be replaced.

In the third type of ascending aortic disease, the configuration is midway between the previous two patterns, that is, there is some dilatation of the annulus and root and some effacement of the sinuses, but these elements are not dramatic. The overall appearance is that of a large tube, rather than a flask. For such aortas, either supracoronary tube grafting or aortic root replacement may be appropriate.

The Crawford classification (Figure 35–2) is used to categorize the appearance of an aneurysm in the descending aorta and thoracoabdominal aorta. This classification is based on the longitudinal location and extent of aortic involvement and has implications for surgical strategy and affects the risk of perioperative complications.

Figure 35–2.

The Crawford classification of descending and thoracoabdominal aneurysms. See text for description of each type.

(Reprinted, with permission, from Edmunds LH Jr, ed. Cardiac Surgery in the Adult. New York: McGraw-Hill, 1997.)

Type I aneurysms involve most of the thoracic aorta and the upper abdominal aorta. Type II aneurysms, the most extensive and most dangerous to repair, involve the entire descending and abdominal aortas. Type III aneurysms involve the lower thoracic and abdominal aortas. Type IV aneurysms are predominantly abdominal but involve thoracoabdominal exposure because of the proximity of the upper border to the diaphragm.

Etiology

The genetics of Marfan disease, a well-known cause of aneurysms of the thoracic aorta, have been well delineated, with over 85 mutations identified at one locus on the fibrillin gene.

Increasingly, it is being appreciated that patients who do not have Marfan disease also manifest familial clustering of thoracic aortic aneurysms and dissections. Patients with aneurysms often answer one or both of the following questions affirmatively: “Do you have any family members with aneurysms anywhere in their bodies? Did any of your relatives die suddenly or unexpectedly of apparent cardiac causes?” Detailed construction of family trees on over 500 patients with thoracic aneurysm have indicated that 21% of aneurysm probands have a first-degree relative with a known or likely aortic aneurysm. The true number is certainly much higher, as these estimates are based only on family interview and not on head-to-toe imaging of relatives. Figure 35–3 shows the 21 positive family trees of the first 100 families analyzed. The most likely pattern of inheritance appears to be autosomal-dominant with incomplete penetrance. A most recent analysis has shown that the location of the proband’s aneurysm largely influences the location of the aneurysms in the family members. If the proband has an ascending aneurysm, the likelihood is that the family members have ascending aneurysms. If, however, the proband has a descending aneurysm, it is likely that the family members have abdominal aortic aneurysms. These proband-family member observations are in keeping with the general concept that aneurysm disease divides at the ligamentum arteriosum: Ascending and arch aneurysms represent one disease, largely nonarteriosclerotic, while descending and abdominal aneurysms represent another disease, largely arteriosclerotic.

Figure 35–3.

The 21 positive family trees among the first 100 families assessed for genetic patterns of thoracic aortic disease.

Application of modern molecular genetic techniques is successfully making progress toward determining the specific genetic aberrations responsible for these family clusterings and for thoracic aneurysms in general. Specific sites of genetic mutations that underlie many of the instances of familial inheritance, including the so-called TAAD1 (Thoracic Aortic Aneurysm and Dissection 1) locus, has been uncovered. Examination of single nucleotide polymorphisms (SNPs) in the blood of hundreds of patients with thoracic aortic aneurysms via genome-wide surveys using large (> 30,000) SNP libraries has been examined. An “RNA signature” in the blood of patients with thoracic aortic aneurysm was found, which can predict with about 85% accuracy from a blood test alone whether the patient harbors a thoracic aortic aneurysm. This “signature” is composed of specific RNAs that are either markedly up-regulated or markedly down-regulated in aneurysm patients, compared with healthy controls. These RNA profiles reflect alterations in RNA expression brought about by the aneurysm disease. The corresponding analyses of DNA polymorphisms, which would reflect the underlying mutations in the genome, is nearing fruition.

Patients who have a genetic predisposition for aneurysm development, specifically those patients with annuloaortic ectasia or ascending dissection, are significantly protected from arteriosclerosis (Figure 35–4). It appears likely that the same mutations that promote lysis of the aortic wall also prevent plaque build-up.

Figure 35–4.

Difference in overall calcification scores relative to the control group for all risk factors analyzed. Note that patients with ascending aortic dissection or annuloaortic ectasia are significantly “protected” from arteriosclerosis, manifesting lower calcification scores. Dis, ascending aortic dissection; AAE, annuloaortic ectasia; G, male gender; HTN, hypertension; Smoke, smoking history; Dyslip, dyslipidemia; DM, diabetes mellitus; Age, age (in 10-year intervals).

Accepting that most patients with aneurysms have an underlying genetic predisposition to the condition, how does this genetic programming lead to the development of an aneurysm? Rapid progress is being made in elucidating these mechanisms. Aneurysm formation is currently thought to involve the following processes (Figure 35–5): extracellular matrix proteolysis, chronic inflammation, cytokine activity, and smooth muscle cell loss. The identification of these mechanisms raises the intriguing possibility of interfering pharmacologically with this pathophysiology, so aneurysm formation or progression can be stopped. The importance of the transforming growth factor- (TGF-) pathway in aneurysm formation has been demonstrated; the ability of angiotensin receptor blocking medications (eg, losartan) to interfere with this pathophysiologic mechanism is being tested, and experimental results are promising. At this time, however, it may be said that no specific pharmacologic strategy exists for delaying aneurysm progression. Results of trials of proteolytic antagonists and -blockers have been underwhelming. The potential roles of statin medications, antiinflammatory agents (cyclooxygenase [COX]-2 inhibitors), immunosuppressants (sirolimus), and antibiotics (doxycycline), are being investigated.

Figure 35–5.

Diagram illustrating the overlapping cellular and molecular processes that contribute to aortic aneurysm formation.

The proteolytic enzymes called matrix metalloproteinases (MMPs) are receiving extensive attention in aneurysm pathophysiology. These powerful enzymes are found in excess in thoracic aortic aneurysms (Figure 35–6) and are thought to play a major role in destroying the substance of the aortic wall, leading to decreases wall strength and, ultimately, dilatation and rupture.

Figure 35–6.

Note overabundance of matrix metalloproteinase (MMP)-1 and MMP-9 in aortas of patients with thoracic aortic aneurysm, compared with controls. This information suggests an important role for MMP enzymes in the pathophysiology of aneurysm disease.

The biologic changes in the aortic wall discussed above are vitally important, but hemodynamic forces need to be considered as well. As the ascending aorta reaches a diameter of 6 cm, the distensibility vanishes, so that the aorta becomes essentially a rigid tube (Figure 35–7). Because of this rigidity, the force of systole can no longer be beneficially dissipated by elastic expansion of the aorta, and this translates into increased wall stress. Especially at high blood pressures, this wall stress becomes excessive, setting the stage for disruption of the aortic wall via rupture or dissection. It is instructive to note how closely this mechanical data dove-tails with the clinical behavior of the aorta: The mechanical properties deteriorate at 6 cm diameter, and that is precisely the hinge point for clinically manifest rupture and dissection.

Figure 35–7.

A: Distensibility values in normal aortas and aortic aneurysms of different diameters. Distensibility of ascending aortic aneurysms decreases rapidly as diameter increases, to very low values at dimensions > 6 cm. At 6 cm, the aorta is essentially a rigid tube, unable to dissipate the force of systole by expanding phasically during the cardiac cycle. B: Exponential relationship between wall stress and aneurysm size in ascending aortic aneurysms. The dark columns represent a blood pressure of 100 mm Hg, and the light columns represent a blood pressure of 200 mm Hg. The lines at 800–1000 kPa represent the range of maximum tensile strength of the human aorta. Note that a patient with a 6-cm aneurysm and a blood pressure of 200 mm Hg (as during stress or extreme exertion) “flirts” with the limits of the ultimate strength of his or her aorta wall.

Clinical Findings

Natural History

The Yale computerized database now contains information on nearly 3000 patients with thoracic aortic aneurysm, including some 9000 tabulated serial imaging studies and 9000 patient-years of follow-up. This database and these methods of analysis have permitted assessment of multiple fundamental topics and questions regarding the natural behavior of the thoracic aorta and have shed light on appropriate criteria for surgical intervention.

How Fast Does the Thoracic Aorta Grow?

Calculation of growth rate of the aorta is more complicated than simply subtracting the original size of the aorta from the current size and dividing by the length of follow-up. Different modalities (echocardiography, computed tomographic [CT] scan, and magnetic resonance imaging [MRI]) may give different values. In addition, some interobserver variability may occur in size assessment. And, most importantly, some scans may show smaller size than original measurements. (This does not imply that the aorta gets smaller, but rather that variability in measurement can happen, especially in huge samples of data.) If these negative changes are truncated, falsely high growth rates result. Via specifically developed statistical methods designed to account for these potential sources of error, the annual growth rate of an aneurysmal thoracic aorta has been determined to be 0.12 cm on average. The descending aorta grows faster than the ascending aorta, at 0.19 cm/year compared with 0.07 cm/year. Also, the larger the aorta becomes, the faster it grows.

At What Size Does the Aorta Dissect or Rupture?

Critical to decision-making in aortic surgery is an understanding of when complications occur in the natural history of unrepaired thoracic aortic aneurysms. In the case of the thoracic aorta, the two complications that are vitally important are rupture and dissection. Knowing when these complications are likely would permit rational decision-making regarding elective, preemptive surgical intervention to prevent them.

Size criteria apply only to asymptomatic aneurysms. Symptomatic aneurysms should be resected regardless of size. The usual symptom produced by an aortic aneurysm is pain. For ascending aneurysms, this pain is usually felt anteriorly, under the breastbone. For descending thoracic aneurysms, the pain is usually felt in the interscapular region of the upper back. For thoracoabdominal aneurysms, the pain is usually felt lower in the back and in the left flank. Other symptoms may occasionally be produced by thoracic aortic aneurysms, including bronchial obstruction, esophageal obstruction, and phrenic nerve dysfunction, and also constitute indications for surgical intervention.

Initial statistical analysis revealed sharp “hinge points” (Figure 35–8) in aortic size at which rupture or dissection occurred. For the ascending thoracic aorta, the hinge point occurs at 6.0 cm. By the time aortas reach this size, 31% have ruptured or dissected. For the descending aorta, the hinge point is located at 7.0 cm. By the time descending aortas reach this size, 43% have ruptured or dissected.

Figure 35–8.

The “hinge-points” (arrows) in the cumulative, life-time incidence of complications (rupture or dissection) of thoracic aortic aneurysms, based on size. By the time the aorta reaches the dimensions on the x -axis, the percentage of patients shown on the y -axis has already incurred rupture or dissection. A: Curve for the ascending aorta. B: Curve for the descending aorta.

If a surgeon were to wait for the aorta to achieve the median size at time of complications in order to intervene, by definition rupture or dissection would have occurred in half of the patients (Figure 35–9). Accordingly, it is important to intervene before the median value is attained. The following recommendations take this factor into account, permitting preemptive surgical extirpation before rupture or dissection in most patients.

Figure 35–9.

A schematic representation of the importance of selecting a criterion for intervention before complications (rupture or dissection) commonly occur. Utilization of the median as the criterion level would allow half the population to realize a devastating complication before preemptive intervention. Accordingly, a criterion below the median is selected (arrow), to allow preemptive intervention before a large proportion of patients have suffered a complication.

Current recommendations are listed in Table 35–1 and are based on the hinge points noted in Figure 35–8. Specifically, prophylactic extirpation of the aneurysmal ascending aorta is recommended when the aneurysm measures 5.5 cm; for the descending aorta, which does not rupture until a larger size, surgical intervention is recommended when the aneurysm measures 6.5 cm. Application of these criteria will prevent most ruptures and dissections, without prematurely exposing the patient to the risks and inconveniences of surgery.

Table 35–1. Size Criteria for Surgical Intervention for Asymptomatic Thoracic Aortic Aneurysm.

  Marfan’s Non-Marfan’s
Ascending 5.0 cm 5.5 cm
Descending 6.0 cm 6.5 cm

It is well-known that patients with Marfan disease are prone to unpredictable dissection at an early size. For this reason, earlier intervention is recommended for patients with Marfan disease as indicated in Table 35–1.

For patients with a positive family history, but without Marfan disease, the same criteria is applied as for Marfan disease because the data indicate malignant behavior of the aneurysm in these patients as well.

If the patient has a positive family history, or if an afflicted family member has suffered rupture, dissection, or death, preemptive surgical extirpation is carried out earlier than otherwise.

Studies of aortic anatomy increasingly recognize that patients with a bicuspid aortic valve also have inherently deficient aortas. Therefore, lower intervention dimensions are used for patients with bicuspid aortic valve as well. Table 35–2 indicates that a bicuspid aortic valve is actually a more common cause of aortic dissection than Marfan disease. Table 35–2 compares the general incidence of Marfan disease with that of bicuspid aortic valve. Although the incidence of dissection is 5% for bicuspid valve disease, compared with 40% for patients with Marfan disease, bicuspid valve disease is so much more common that it causes more total cases of dissection than Marfan disease. This factor must be taken into account in planning surgical repair of the ascending aorta of the patient with a bicuspid aortic valve when the aorta is still in the aneurysmal stage, and not yet a dissection.

Table 35–2. Aortic Manifestation of Connective Tissue Disease.

  Incidence in General Population Rate of Dissection (per affected individual) Number of Dissections Caused (per 10,000 population)
Marfan syndrome 0.01% (1 in 10,000) 40% 0.4 persons
Bicuspid aortic disease 1–2% (100–200 in 10,000) 5% 5–10 persons

What Is the Yearly Rate of Rupture or Dissection for Thoracic Aortic Aneurysms?

The preceding data indicate the cumulative lifetime rates of dissection or rupture by the time the aorta reaches a certain size. Determining the yearly risk of complications from the natural history of thoracic aortic aneurysm is more challenging because it requires extremely robust data. Such data must produce enough hard end points to permit analysis within a year’s time for different size strata. The following equation calculates the yearly rate of rupture:

Calculations of yearly rates of rupture or other complications based on size of the aorta have also been produced. These yearly rates are expressed based simply on the size of the aorta (Figure 35–10).

Figure 35–10.

Probabilities that rupture, dissection, or death will occur have been calculated for aortic aneurysms in the chest. The likelihood of these events jumps sharply for aneurysms that reach 6 cm or higher.

These data all point to a diameter of 6 cm as a very dangerous size threshold. At or above this size, the yearly risk for rupture is about 4%, the yearly risk of dissection is about 4%, and the risk of death is about 11%. (Death is often directly related to catastrophic complications from the aneurysm.) The chance of any one of these phenomena occurring—rupture, dissection, or death—is 14%/year. As a mnemonic point of reference, a 6-cm aneurysm can be equated to about the diameter of a soft-drink can. When a thoracic aortic aneurysm reaches the diameter of a soda can, it has certainly attained the point where it poses a major risk to the patient.

These analyses should permit accurate decision making when seeing a patient during an office visit and considering preemptive surgical extirpation of thoracic aneurysms. These data allow the physician to form a reasonable estimate of the individual patient’s risk of dissection, rupture, or death for each future year of life, if the aorta is not resected. The risk of rupture, dissection, or death based on aortic size is presented graphically in Figure 35–10.

The question arises whether the same surgical intervention criteria should apply for a small woman as for a large man. It is true that a larger individual can be “allowed” a larger aorta, generally speaking. Conversely, even a moderate-sized aneurysm can be quite threatening in an individual of small stature. For this reason, adverse event rates (rupture or dissection) based on aortic size corrected for body surface area (BSA) have been analyzed. By plotting the aneurysm size along the horizontal scale and the BSA along the vertical scale, each particular patient can be classified into low-, medium-, or high-risk categories—thus taking account of the aneurysm size in relation to the patient’s physical size.

Symptoms and Signs

Most thoracic aortic aneurysms are asymptomatic and are detected fortuitously during imaging of other thoracic structures. When they are symptomatic, deep visceral pain in the upper anterior chest or interscapular back can occur. This pain differs from angina pectoris because it is not necessarily precipitated by exertion nor relieved by rest or nitroglycerin. Often, it is rather constant and not influenced by body motion or position. All patients with chest pain should have a screening chest radiograph. Rupture of a thoracic aneurysm usually causes excruciating pain, accompanied by profound dyspnea as the chest fills with blood, and quickly results in shock. A large ascending aortic aneurysm occasionally may result in dysphagia or stridor due to esophageal or large airway obstruction. Rarely, a large aneurysm may cause bone pain due to pressure against thoracic skeletal structures.

Physical Examination

Physical examination is usually unremarkable. The presence of a murmur of aortic regurgitation should raise the suspicion of ascending aortic aneurysm, as should features suggestive of Marfan syndrome or related conditions. Rarely, an abnormal pulsation will be felt due to a large aneurysm contacting the chest wall.

Diagnostic Studies

The remarkable strides made in recent decades in three-dimensional body imaging have dramatically advanced the diagnosis and treatment of thoracic aortic aneurysm. Echocardiography (especially transesophageal) and CT and MRI scans all yield images that clarify the presence, location, size, and extent of aneurysmal disease. An example of the precise imaging afforded by MRI is indicated for a specific, very extensive aneurysm in Figure 35–11.

Figure 35–11.

Magnetic resonance scan of massively dilated aorta, which extends from the aortic valve to the iliac bifurcation. Note that the heart is compressed to a small shadow crushed between the elongated aorta and the diaphragm. This aneurysm was successfully resected in two stages.

In this era of specialized three-dimensional imaging, it is important not to forget the chest radiograph, which can often yield significant information about the thoracic aorta. An example is provided in Figure 35–12. Ascending aortic aneurysm presents as a bulge beyond the right hilar border. Arch aneurysm produces enlargement of the aortic knob. Descending thoracic aneurysm is often easily seen as a deviation of the stripe of the descending aorta, which normally runs parallel to and just left of the vertebral column.

Figure 35–12.

An exemplary chest radiograph indicating that significant information about the aorta can be gleaned from this simple test. Note the bulge of the ascending aorta to the right of the upper mediastinal border. This young patient with Marfan disease suffered dissection at an ascending aortic dimension of 4.8 cm.

Treatment

Risks of Aortic Surgery

It is certainly helpful to know numerically and statistically the cumulative and yearly rates of rupture, dissection, and death imposed by an aortic aneurysm of a specific size. On the other hand, the equation is incomplete without consideration of the risks inherent in elective, prophylactic surgical extirpation of the thoracic aorta. Certainly these are major operations, and the surgical risks most feared include death, stroke, and paraplegia. However, these operations have become safer, reflecting increased surgical experience, improved perfusion techniques, improved (non-porous) grafts, effective anti-fibrinolytic agents for perioperative use, improved methods of spinal cord preservation, and the advent of centers specializing in aortic care and surgery. A recently published report emphasizes the “safety of thoracic aortic surgery in the present era.” Mortality rates and rates of other complications after aortic surgery are quite low, especially for operations performed electively on stable patients, in whom the safety of ascending aortic and aortic arch surgery is as high as 98%. Table 35–3 shows the pertinent rates of morbidity and mortality.

Table 35–3. Current Risks of Thoracic Aortic Surgery.

  Mortality (%) Stroke (%) Paraplegia (%)
Ascending/arch 2.9 3.0 0.5
Descending/ thoracoabdominal 2.9 4.2 5.3

Data are for elective procedures, which is the category to whom surgical decision criteria are applied. Data from Achneck H, Rizzo JA, Tranquilli M, Elefteriades JA. Safety of thoracic aortic surgery in the present era. Ann Thorac Surg. In press.

These rates are typical of those at other centers with a focused interest and a specific program in thoracic aortic diseases. It should be noted that stroke can complicate not only ascending and arch operations, but also descending aortic operations.

Indications and Contraindications

By considering the rates of natural rupture, dissection, and death from the thoracic aneurysm itself versus the risks of operation, the physician can make an informed recommendations about elective, preemptive surgery. Once patients and their families are provided the natural history and surgical risk data, they often have strong opinions of their own. Some patients are reluctant to undergo major surgery, with its significant attendant risks, for an asymptomatic problem. Most patients, however, seem to feel they will never be comfortable until the threatening aneurysm is resected.

One more very important general point needs to be considered. Once the aorta has dissected, the prognosis is thereafter adversely affected (Figure 35–13). Patients who required emergency surgery not only had a higher rate of early mortality, but their survival curve was dramatically poorer. The patients who elected for surgery showed a survival rate very similar to that of a normal population. The poor long-term outlook for patients who required emergency surgery is due largely to the fact that, even after surgical replacement of portions of the aorta, the remainder of this vital organ will forever remain dissected. Because the aortic wall was deficient to start with, at half-thickness, after dissection, it is rendered even more vulnerable to subsequent enlargement and rupture.

Figure 35–13.

Long-term survival rates based on treatment. Medically treated patients had, of course, smaller and less symptomatic aneurysms. Note particularly that patients having emergent surgery not only manifested a higher likelihood of perioperative mortality, but also had a poorer long-term outlook. On the other hand, patients who received elective surgery, showed excellent survival rates, comparable to an age and sex-matched normal population. This data argues for elective, prophylactic extirpation of the aneurysmal aorta, before rupture or dissection can occur.

Surgical Techniques

As discussed, the type of operation for the ascending aorta is based on the pattern of aneurysmal pathology. For many patients, a supracoronary tube graft suffices (Figure 35–14A). For others, a composite graft, including both a valve and a graft, with obligate coronary artery reimplantation, is appropriate (Figure 35–14B). New valve-sparing aortic replacement procedures have been developed. The appropriate application of these procedures will become clearer as more patients are monitored into the medium term and as more centers accumulate experience with these innovative techniques.

Figure 35–14.

A: Supracoronary tube graft replacement and B: composite graft replacement.

(A: Reprinted, with permission, from Cooley DA, Wukasch DC. Techniques in Vascular Surgery. Philadelphia: WB Saunders, 1979.)

The main debate regarding the procedure for ascending aortic operations and those on the aortic arch concerns the optimal means of protecting brain function during the time that anastomoses in the vicinity of the aortic arch are performed. Deep hypothermic circulatory arrest—a state of suspended animation, which is generally safe for 30–45 minutes or longer—is preferred by many surgeons, for its simplicity and effectiveness. In a study on 400 patients, the effectiveness of this remarkable technique as a sole means of brain preservation was confirmed. Retrograde cerebral perfusion—via the superior vena cava—has its advocates, although the actual amount of effective brain perfusion achieved by this means has been questioned. Direct perfusion of the head vessels—usually via a cannula in the innominate artery or cannulas in both the innominate and the left carotid artery—also has its supporters, despite its added complexity. Direct perfusion is gaining in popularity, and it does provide a margin of protection, especially for very complex arch reconstructions or for surgical teams relatively inexperienced with arch replacement. No technique has been demonstrated conclusively superior over the others. Some recent attempts have been made to develop a solution and technique for “cerebroplegia,” which takes a cue from the paralyzing cardioplegia used to protect the heart, without success.

For descending and thoracoabdominal operations, the technique of left atrial to femoral artery bypass has become extremely popular. This method takes strain off the heart by diverting blood away from the left ventricle. This approach mitigates the effect of high aortic cross-clamping on cardiac afterload. It also perfuses the lower body, especially the extremely vulnerable spinal cord. Despite decades of concerted attention, paraplegia from descending and thoracoabdominal aortic replacement continues to be a major clinical problem. The cause is multifactorial, with clamp time, air and particulate embolism, and disconnection of critical intercostal branches all playing a role. Besides the benefits of left atrial to femoral artery perfusion, most authorities feel that routine spinal fluid drainage and deliberate maintenance of a strong postoperative blood pressure (to encourage collateral blood flow) are also effective adjuncts against the complication of postoperative paraplegia.

Specific Clinical Scenarios and Issues

Patient with Pain, But Aneurysm Smaller Than Criteria

The answer to whether such an aorta should be replaced is a resounding yes. The dimensional criteria are specifically intended for asymptomatic patients. Any and all symptomatic aneurysms need to be resected because symptoms are a precursor to rupture. Aneurysm pain represents stretching or irritation of the aortic adventitia, the adjacent chest wall, the mediastinal pleura, or some other structure impinged on by the expanding aneurysm. Even an aorta smaller than the criterion can rupture or dissect. Such a patient is of extreme concern, and preemptive resection is needed. In one case, a patient complained of typical pain of an ascending aortic aneurysm. The aorta was 5.0 cm. Because the medical team thought this was too small for resection, they underestimated the symptoms at presentation. The aorta subsequently ruptured and the patient died within 48 hours. This point cannot be overemphasized: The size criteria are explicitly intended only for asymptomatic patients; all symptomatic aneurysms need to be resected.

Differentiating Aneurysm Pain from Musculoskeletal Pain

This very important point is not always easy to determine, even in the most experienced hands. The patient usually has a good sense of whether the pain is originating from muscles and joints. The clinician usually gets an additional understanding by asking the following questions:

a. Is the pain influenced by motion or position? (If so, it is probably musculoskeletal.)
b. Do you have a history of lumbosacral spine disease or chronic low back pain? (If so, the symptoms may not be aortic in origin.)
c. Do you feel the pain in the interscapular back? (An affirmative answer indicates an almost certain relationship to thoracic aortic aneurysm.)

Presume that the pain is aortic in origin if no other cause can be conclusively established. This is the only approach that can prevent rupture.

Appropriate Interval for Serial Aortic Imaging

Patients with a thoracic aortic aneurysm should be monitored indefinitely. Stable, asymptomatic patients can undergo imaging about once every 2 years, remembering that the aneurysmal aorta grows at a relatively slow 1 mm/year. In case of new onset of symptoms, imaging should be done promptly, regardless of the interval from the prior scan. For new patients, for whom only one size data point is available, imaging should be done at short intervals until the behavior of aorta is understood. Imaging may be done every 3–6 months for new patients with moderately large aortas. Remember to compare the present scan with the patient’s first scan, not with the last prior scan. That is the way to detect growth. Many a patient has suffered because scans were only compared with the last prior scan, and major growth went undetected.

Choice of Imaging Modality for Serial Follow-Up

Three quality imaging techniques are currently available: echocardiography, CT scan, and MRI. If echocardiography is chosen, it is important to remember that a standard transthoracic echocardiogram cannot see the distal ascending aorta, the aortic arch, or the descending aorta with conclusive accuracy because of intervening air-containing lung tissue. Supplement such studies with a periodic CT scan or MRI, which can visualize the entire aorta. The choice between CT and MRI may depend on ease of availability and radiologic expertise in a particular environment. Both modalities can image the entire aorta extremely well. Elevated creatinine or contrast allergy may contraindicate CT and instead favor MRI. The need to evaluate complex aortic lesions in multiple imaging planes would also favor MRI (although very recently concerns have been raised about the risk to the kidneys of gadolinium contrast agents used for MRI scanning). Of course, indwelling metallic foreign objects, such as pacemakers or metal artifacts from previous surgery, may make CT the necessary choice instead of MRI.

Evaluation of Family Members

The data on familial inheritance has become strong enough that the treating physician is obligated to recommend that family members be evaluated. Physicians of family members should be made aware that aneurysm disease has been diagnosed in the family. A CT scan is recommended for adult males and for females beyond childbearing age. For children and for females of childbearing age, echocardiography of the ascending aorta and abdominal aorta is recommended. Investigators hope to identify humoral markers or genetic aberrations that can be used for familial screening of the aneurysm trait soon.

Activity Restrictions

Continuation of any and all aerobic activities, including running, swimming, and bicycling is recommended. Serious weight lifters, at peaks of exertion, can elevate systolic arterial pressure to 300 mm Hg. This type of instantaneous hypertension is, of course, not prudent for aneurysm patients. Weight lifters should limit themselves to one-half their body weight. The evidence for effort-induced aortic dissection is mounting. Participation in contact sports or those that might produce an abrupt physical impact, such as tackle football, snow skiing, water skiing, and horseback riding, is proscribed.

Role of Stent Grafting

A word of caution is appropriate concerning stent grafts. Multiple thoracic stent products previously in clinical trials have been recalled by the US Food and Drug Administration. Owing to the very high need for subsequent conventional surgery after abdominal aneurysm stent placement, the recent large, multicenter Eurostar study questioned the very efficacy and advisability of stent grafting. Endoleak, stent dislodgement, and aneurysm expansion or rupture were disturbingly widespread in medium-term follow-up. It should be remembered that stents were designed to keep tissue from encroaching on the vessel lumen, not to keep the vessel from expanding. One noted authority believes that the aneurysmal aorta essentially “ignores” the stent graft, dilating regardless of the stent, at its own pace. (Personal communication, Dr. L. Svennson.) Also remember that the natural history of the thoracic aorta is that they grow slowly, and that hard end points (rupture, dissection, and death) take years to be realized. For this reason, short-term stent studies are nearly meaningless. Long-term studies are needed. This new modality should be approached with enthusiasm tempered by caution. Its advent should not at this point influence overall intervention strategy.

Achneck HE et al. Safety of thoracic aortic surgery in the present era. Ann Thorac Surg. 2007 Oct;84(4):1180–5. [PMID: 17888967]

Coselli JS et al. Cerebrospinal fluid drainage reduces paraplegia after thoracoabdominal aortic aneurysm repair: results of a randomized clinical trial. J Vasc Surg. 2002 Apr;35(4):631–9. [PMID: 11932655]

David TE. Aortic valve-sparing operations for aortic root aneurysm. Semin Thorac Cardiovasc Surg. 2001 Jul;13(3):291–6. [PMID: 11568875]

Davies RR et al. Yearly rupture or dissection rates for thoracic aortic aneurysms: simple prediction based on size. Ann Thorac Surg. 2002 Jan;73(1):17–27. [PMID: 11834007]

Davies RR et al. Novel measurement of relative aortic size predicts rupture of thoracic aortic aneurysms. Ann Thorac Surg. 2006 Jan;81(1):169–77. [PMID: 16368358]

Elefteriades JA. Beating a sudden killer. Sci Am. 2005 Aug;293(2):64–71. [PMID: 16053139]

Elefteriades JA et al. Endovascular stenting for descending aneurysms: wave of the future or the emperor’s new clothes? J Thorac Cardiovasc Surg. 2007 Feb;133(2):285–8. [PMID: 17258546]

Elefteriades JA et al. Litigation in nontraumatic aortic diseases—a tempest in the malpractice maelstrom. Cardiology. 2008;109(4): 263–72. [PMID: 17873491]

Goldstein LJ et al. Stroke in surgery of the thoracic aorta: incidence, impact, etiology, and prevention. J Thorac Cardiovasc Surg. 2001 Nov;122(5):935–45. [PMID: 11689799]

Habashi JP et al. Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome. Science. 2006 Apr 7;312(5770):117–21. [PMID: 16601194]

Hasham SN et al. Mapping a locus for familial thoracic aortic aneurysms and dissections (TAAD2) to 3p24-25. Circulation. 2003 Jul 1;107(25):3184–90. [PMID: 16847387]

Koullias GJ et al. Increased tissue microarray matrix metalloproteinase expression favors proteolysis in thoracic aortic aneurysms and dissections. Ann Thorac Surg. 2004 Dec;78(6):2106–10. [PMID: 15561045]

Laheij RJ et al. Need for secondary interventions after endovascular repair of abdominal aortic aneurysms. Intermediate-term follow-up results of a European collaborative registry (EUROSTAR). Br J Surg. 2000 Dec;87(12):1666–73. [PMID: 11122182]

Svensson LG et al. Prospective randomized neurocognitive and S-100 study of hypothermic circulatory arrest, retrograde brain perfusion, and antegrade brain perfusion for aortic arch operations. Ann Thorac Surg. 2001 Jun;71(6):1905–12. [PMID: 11426767]

Aortic Dissection

Essentials of Diagnosis

  • Usually middle-aged or elderly hypertensive men; occasionally, young patients with history of Marfan syndrome, other connective tissue disorder. Rarely, young women in late pregnancy or labor.
  • Acute chest pain, frequently with hemodynamic instability.
  • Possible appearance of shock but normal or elevated blood pressure.
  • Various neurologic symptoms, such as Horner syndrome, paraplegia, and stroke.
  • Absent or unequal peripheral pulses.
  • Aortic regurgitation.
  • Widened mediastinum on chest radiograph.
  • Confirmatory aortic imaging study.

General Considerations

Terminology

Aortic dissection refers to a splitting of the layers of the aortic wall (within the media) permitting longitudinal propagation of a blood-filled space within the aortic wall. Aortic dissection is thought to be the most common cause of death related to the human aorta (Figure 35–15).

Figure 35–15.

Schematic depiction of aortic dissection.

Three related but distinct entities—acute aortic transection, rupture of aortic aneurysm, and aortic dissection—are commonly confused, both in substance and in terminology (Figure 35–16). Acute aortic transection is a traumatic phenomenon, with disruption of the wall of the aorta, without a propagating dissection. The aortic wall is intrinsically normal and resistant to the dissection process. Rupture of aortic aneurysm is self-explanatory; however, confusion in terminology may arise if an acute aortic transaction or an acute aortic dissection happens to rupture—a common eventuality. Acute aortic dissection refers to the very specific process of separation of layers of the aortic wall discussed fully in this chapter. For dissection to occur, the aortic wall must nearly always be affected by structural disease of the media.

Figure 35–16.

Frequently confused terminology. See text for a description of the very different disorders of acute aortic transection (A), ruptured aortic aneurysm (B), and acute aortic dissection (C).

Recent years have brought recognition of two important variants of aortic dissection: intramural hematoma (IMH) and penetrating aortic ulcer (PAU) (Figure 35–17).

Figure 35–17.

Schematic of variant forms of aortic dissection: typical dissection, penetrating ulcer, and intramural hematoma. A true dissection has to have a flap.

Intramural hematoma of the aorta differs from typical dissection in that there is no flap defining a true and a false lumen, and the hematoma is located circumferentially around the aortic lumen, rather than obliquely oriented across the aortic lumen. Whether the IMH arises from a small intimal tear (not detected radiographically) or from a rupture of a vasa vasorum within the aortic wall remains controversial. The clinical course is variable; the hematoma may persist, reabsorb (returning the aorta to a normal appearance), lead to aneurysm with the possibility of rupture, or convert to dissection. Penetrating aortic ulcer involves a local penetration deep into the wall of the aorta, resembling a penetrating ulcer of the stomach. This lesion disrupts the internal elastic lamina and erodes into the media, which in some cases may mimic or initiate aortic dissection, pseudoaneurysm formation, IMH, or rupture. Extensive arteriosclerosis is a common accompaniment of PAU (Figure 35–17).

It is important to recognize that IMH and PAU are diseases of advanced age. In addition, it is important point to mention that although branch vessel occlusion is part and parcel of typical aortic dissection, the variants of aortic dissection PAU and IMH never occlude branch vessels.

The general management of these lesions is still a matter of debate. Most authorities believe that descending aortic IMH and PAU can be managed medically, with “anti-impulse” therapy (see Treatment section). However, early (but not immediate) surgical intervention is preferred in suitable operative candidates to preempt rupture due to a high incidence of death from rupture. Some of the discrepancy in recommendations also has to do with regional differences: in Japan, IMH behaves in a more benign fashion than in the Western world, perhaps reflecting fundamental genetic differences in the aortic wall, or differences in body size and aortic dimension.

For ascending variant dissections IMH and PAU, most authorities agree on aggressive immediate surgical intervention, although one recent paper from Japan challenges the need for routine surgery, even in this anatomic location.

Anatomic Classification

Aortic dissections may be ascending (type A) or descending (type B). The two patterns are determined by the location of the inciting intimal tear. Tears occur in two very specific locations: (1) in the ascending aorta, 2–3 cm above the coronary arteries and (2) in the descending aorta, 1–2 cm beyond the left subclavian artery. The first type of tear produces ascending dissection and the second, descending dissection. Please note that ascending dissections usually go around the aortic arch to involve the descending and abdominal portions of the aorta (Figure 35–18).

Figure 35–18.

Stanford classification system.

(Reprinted, with permission, from Daily PO et al. Ann Thorac Surg. 1970;10:244.)

Clinical Findings

Symptoms and Signs

Aortic dissection produces intense, severe pain, often described as tearing or shearing in quality. This pain is sudden in onset (a differentiating feature from the pain of myocardial infarction) and very severe in intensity. Most patients describe this as the most intense pain of their lives, more intense even than childbirth or a kidney stone. The pain of ascending dissection is felt in the anterior chest, substernally, and that of a descending dissection is felt posteriorly, between the scapulae. The “tearing,” “shearing,” “knife-like” quality of the pain is quite consistent with the pathophysiology. The pain can migrate downward, into the flank or pelvis, as the dissection process propagates distally. Impending aortic rupture should be considered when pain subsides and later recurs. On occasion, painless dissection does occur, perhaps as often as 15% of patients; this is usually picked up later, on a routine imaging study done for another reason.

Diagnostic Studies

Chest Radiography

Chest radiography is a useful screening test. Many, if not most, aortic dissections occur in the background of a chronic aortic aneurysm. To the astute observer, chronic thoracic aneurysms can be visualized on a chest radiograph. The enlarged ascending aorta will protrude to the right of the upper mediastinal border, an arch aneurysm will show as an exaggerated aortic knob, and a descending aortic aneurysm will be visible as a left-deviated stripe of the descending aorta. In case of aortic dissection, chest radiography will usually provide additional clues: most commonly, widening of the mediastinal shadow, pleural effusion, or inward displacement of aortic medial calcification.

Three-Dimensional Imaging Methods

Multiple types of three-dimensional imaging modalities are pertinent in aneurysm disease and aortic dissection and all have excellent sensitivity and specificity: transesophageal echocardiography (TEE), CT scanning, and MRI. Many patients undergo a TEE and either a CT or an MRI. The CT or MRI shows the three-dimensional structure of the entire aorta. The TEE, while partially blinded to the aortic arch and abdominal aorta, provides information about pericardial effusion and tamponade, valve function, and left ventricular function. Transesophageal echocardiography images both ascending and descending aortas well.

The primary diagnostic criterion for aortic dissection by CT or MRI is demonstration of two contrast-filled lumens separated by an intimal flap. Sensitivity and specificity of CT and MRI for diagnosis of aortic dissection are approaching 100%. Transesophageal echocardiography does not lag far behind in accuracy. Contrast aortography, once the gold standard, has fallen by the wayside for diagnosis of aortic dissection, being more invasive and not offering nearly the amount of three-dimensional anatomic information afforded by CT, MRI, and TEE.

Differential Diagnosis

The imaging studies discussed above provide specific information that rules in or out the presence of aneurysm or dissection. The main diagnostic issue involves (1) maintaining a high index of suspicion for aneurysm disease and (2) being aware of the protean presentations of aneurysm disease. In particular, aortic dissection has been called “the great masquerader” because it can produce symptoms related to virtually any organ. A high index of suspicion is required to establish the diagnosis promptly, since the presentations of aortic dissection are so myriad and mimic a wide array of other diseases. Specifically, all patients admitted with chest pain without obvious cause should have their thoracic aorta imaged. Patients with a ruptured or dissected thoracic aorta often “masquerade” as heart attacks. It is especially important to rule out aortic dissection in patients about to be treated for myocardial infarction, as administration of thrombolytic drugs in patients with acute aortic dissection is associated with a high mortality rate.

Among conditions for which aortic dissection can be confused are myocardial infarction, musculoskeletal chest pain, pericarditis, pleuritis, pneumothorax, pulmonary embolism, cholecystitis, ureteral colic, appendicitis, mesenteric ischemia, pyelonephritis, stroke, transient ischemic attack, and primary limb ischemia. Especially troublesome to clinicians in emergency departments are patients with abdominal symptoms and signs without apparent abdominal cause; aortic dissection must be considered in such patients.

Given the extensive differential diagnosis, aggressive, objective diagnostic testing is necessary when the possibility of aortic dissection is considered. The diagnosis is most strongly suggested when migratory chest and back pain of less than 24 hours duration arises in a patient with a history of hypertension. The following recommendations are made for the physicians who are the first to evaluate such patients: (1) Keep aortic dissection (and ruptured thoracic or abdominal aneurysm) in the differential diagnosis. (2) Image freely and liberally to rule out aortic pathology. A CT scan can exclude all three major chest diagnoses likely to result in death: coronary artery disease, pulmonary embolism, and aortic aneurysm or dissection. The modern 64-slice scanners are ideal for this purpose. (3) Remember the D -dimer test. A negative D -dimer, which is most commonly applied to rule-out pulmonary embolism, also rules out aortic dissection. The clot that forms in the false lumen of an aortic dissection liberates D-dimer quite strikingly. This simple blood test is nearly 100% sensitive in picking up aortic dissection. (4) Remember to look at the aorta, even if the CT scan is ordered for other, especially abdominal, examination.

Attention to these recommendations will also serve to discourage litigation for failure to diagnose aortic dissection.

Treatment

Pharmacotherapy

Most patients will require intensive medical therapy for acute aortic dissection, either as sole treatment or as a stabilizing measure until appropriate surgical therapy is undertaken.

It has been recognized that aortic dissection propagates more vigorously when either blood pressure or force of cardiac contraction are excessive. Accordingly, blood pressure needs to be controlled in patients with acute aortic dissection or other acute aortic syndromes, including aortic rupture or impending rupture. Nitroglycerin or nitroprusside are usually used for this purpose, because of their effectiveness, their rapid onset of action, and their quick cessation of action upon discontinuation. Blood pressure should be reduced as low as possible without producing neurologic dysfunction or oliguria. Usually, the severity of general occlusive vascular disease determines how low the blood pressure can safely be taken. The blood pressure may be lowered to 90–100 mm Hg initially, until the patient’s response can be evaluated. For older patients with extensive end-organ vascular disease, lowering the blood pressure pharmacologically to 120–130 mm Hg may need to be satisfactory.

However, to lower blood pressure by afterload reduction alone would actually increase the sheer stress on the aortic wall. It is crucial to decrease the force of cardiac contraction (Figure 35–19). The morphology of the arterial pulse wave must be blunted by decreasing the force of cardiac contraction. The dp/dt , reflected in the upslope of the initial portion of the aortic pulse wave, must be decreased, usually by administering a short-acting -blocker, such as esmolol. Another approach is administration of the – and -adrenergic antagonist labetalol by intravenous infusion. When -blocking drugs are contraindicated, calcium channel blockers are a reasonable substitute.

Figure 35–19.

Diagram of aortic pressure curves under various conditions. The continuous line (B) represents the baseline state. Administration of a vasodilator agent such as nitroprusside is represented by the dashed curve (A). There is significant decrease in pressure levels and acceleration in heart rate, but this is accompanied by a steepest slope of the ascending portion of the curve (increased dp/dt   max). -Blockade administration is represented by the dotted line (C). Although the degree of pressure lowering is usually smaller, the drug negative inotropic and chronotropic effects result in decreased impulse and dp/dt  max.

Together, the afterload reduction and the -blockade are referred to as “anti-impulse” therapy for acute aortic dissection. Regardless of whether the dissection is ascending or descending, or whether or not the patient will be taken emergently to the operating room, such therapy must be instituted—to discourage rupture or extension of the dissection. Anti-impulse therapy is the appropriate initial response once the diagnosis of any type of acute aortic dissection or related process is made. Often, such therapy is undertaken while imaging studies are being performed to confirm the diagnosis of aortic dissection and define the anatomic type, location, and extent of the process. Definitive therapeutic decisions and treatments will follow.

Surgical Treatment

For acute aortic dissection, the following guidelines regarding definitive therapy apply.

Ascending aortic aneurysms require urgent surgery because death from intrapericardial rupture, aortic regurgitation, or myocardial infarction from coronary artery involvement usually occurs in patients who do not undergo surgery. The dissection layers are reapproximated as a “sandwich” between layers of Teflon felt (Figure 35–20). Overall survival at experienced centers is about 85% for patients with acute type A aortic dissection. The exact surgical procedure performed, vis-à-vis the proximal aortic root and the coronary arteries varies depending on the circumstances. For patients in whom dissection occurs in the setting of Marfan disease or other cause of annuloaortic ectasia (proximal root enlargement), the aortic valve, aortic root, and ascending aorta are replaced with a prefabricated “composite graft” including both a valve and a graft (see Figure 35–15B).

Figure 35–20.

Alternate methods of dealing with the dissection prior to anastomosis.

Descending dissections, in the absence of specific vascular complications, do well with medical management (short- and long-term “anti-impulse” therapy with -blockers and afterload-reducing medication). If a specific complication occurs, this is addressed directly by surgery (“complication-specific” approach to descending aortic dissection). Ninety-one percent of patients survived the initial hospitalization (type B aortic dissection is “milder” than type A dissection) and about 66% had a completely uncomplicated course while receiving anti-impulse medical therapy alone. The majority of complications were related to vascular malperfusion of specific organs.

The subacute and chronic stages of aortic dissection are managed differently. Once the patient with type A dissection has been brought safely through surgery, or the type B patient has been stabilized with anti-impulse therapy, they are observed closely for the first month, with repeat aortic imaging. After that point, it is uncommon for the dissection to extend, cause symptoms, or rupture in the short-term to mid-term. The patients are then monitored the same as those with chronic aneurysm. Over years, enlargement of the dissected aorta will develop in some patients and require resection. The same dimensional criteria for surgical intervention can be applied as for non-dissected aneurysms. It is usually the most proximal portion of the descending aorta, just beyond the subclavian artery, that dilates first and requires surgical replacement.

Prognosis

Aortic dissection is often fatal without early diagnosis and aggressive treatment. The presenting symptoms and signs are so myriad and nonspecific (see above) that dissection may be overlooked initially in up to 40% of cases; in fact, the diagnosis is not made until postmortem examination in a disturbingly large fraction of patients. This can be a frequent cause of litigation, and guidelines have recently been outlined so litigation can be avoided. Few other conditions demand such prompt diagnosis and treatment, since the mortality rate of untreated dissection approaches 1–2% per hour during the first 48 hours, 89% at 14 days, and 90% at 3 months.

Aortic dissection can result in death in four ways: (1) intra-pericardial rupture (of an ascending dissection), (2) acute aortic regurgitation (from an ascending aortic dissection), (3) free rupture into the pleural space (of a descending dissection), and (4) occlusion of any branch of the aorta (with consequent organ ischemia).

Branch vessel occlusion comes about via impingement on the true lumen of any branch vessel (coronaries to iliacs) by the distended false lumen (Figure 35–21). The acute aortic regurgitation of an ascending dissection may be very poorly tolerated, compared with chronic aortic regurgitation, because the sudden nature allows no time for cardiac adaptation. Cardiogenic shock may result.

Figure 35–21.

Depiction of means by which the dissected lumen can compromise the true lumen, seen in various planes. The figures on the left look at the aorta itself. Note the relief of impingement when the flap fenestrates (images left, C and D and right, C).

Elefteriades JA. What operation for acute Type A dissection? J Thorac Cardiovasc Surg. 2002 Feb;123(2):201–3. [PMID: 11828276]

Hatzaras IS et al. Role of exertion or emotion as inciting events for acute aortic dissection. Am J Cardiol. 2007 Nov 1;100(9):1470–2. [PMID: 17950810]

Hatzaras I et al. Weight lifting and aortic dissection: more evidence for a connection. Cardiology. 2007;107(2):103–6. [PMID: 12821554]

Tittle SL et al. Midterm follow-up penetrating ulcer and intramural hematoma of the aorta. J Thorac Cardiovasc Surg. 2002 Jun;123(6):1051–9. [PMID: 12063450]

Copyright © The McGraw-Hill Companies.  All rights reserved.
Privacy Notice. Any use is subject to the Terms of Use and Notice.

McGraw-Hill Education A Silverchair Information System The McGraw-Hill Companies

Leave a Reply


Time limit is exhausted. Please reload the CAPTCHA.

Categories

apply_now Pepperstone Group Limited